Cargando…
Clinical Research after COVID-19: Embracing a New Normal
The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a...
Autores principales: | Gelfand, Joel M., Hefele, Brooke E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466954/ https://www.ncbi.nlm.nih.gov/pubmed/32890628 http://dx.doi.org/10.1016/j.jid.2020.08.004 |
Ejemplares similares
-
Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
por: Ferreira da Silva, Renato, et al.
Publicado: (2023) -
Why Mayo Clinic Is Embracing the Cloud and What This Means for Clinicians and Researchers
por: Ryu, Alexander J., et al.
Publicado: (2021) -
Telemedicine: Embracing virtual care during COVID-19 pandemic
por: Garg, Suneela, et al.
Publicado: (2020) -
Telemedicine in pediatric rheumatology: this is the time for the community to embrace a new way of clinical practice
por: Shenoi, Susan, et al.
Publicado: (2020) -
Lifestyle Medicine and Otolaryngology: Embracing the Future
por: Juszczak, Hailey M., et al.
Publicado: (2021)